Join to View Full Profile
7200 Cambridge StHouston, TX 77030
Phone+1 713-798-8259
Fax+1 713-798-7709
Dr. Mandel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jacob Mandel is a neurologist in Houston, TX and is affiliated with Baylor St. Luke's Medical Center. He received his medical degree from Rush Medical College and has been in practice 9 years. He specializes in neurooncology and is experienced in neuro-oncology.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2014
Ohio State University HospitalResidency, Neurology, 2009 - 2012- Ohio State University HospitalInternship, Internal Medicine, 2008 - 2009
Rush Medical College of Rush University Medical CenterClass of 2008
Certifications & Licensure
TX State Medical License 2014 - 2025
OH State Medical License 2008 - 2014
American Board of Psychiatry and Neurology Neurology
UCNSNeuro-Oncology
Publications & Presentations
PubMed
- Low-grade glial/glioneuronal tumor with YAP1::FAM118B fusion: A novel molecular finding.Fouad El-Dana, Kenneth Aldape, Zied Abdullaev, Sameer Anil Sheth, Jacob Mandel
Journal of Neuropathology and Experimental Neurology. 2025-04-01 - Discontiguous recurrences of IDH-wildtype glioblastoma share a common origin with the initial tumor and are frequently hypermutated.Malcolm F McDonald, Sricharan Gopakumar, Tareq A Juratli, Ilker Y Eyüpoglu, Ganesh Rao
Acta Neuropathologica Communications. 2025-01-16 - Isolated calvarial lesion as the initial presentation of metastatic hepatocellular carcinoma: A case report and review of the literature.Jeffrey Wu Chen, Nisha Giridharan, Arman A Kavoussi, Dawn Van Arsdale, Shervin Hosseingholi Nouri
Surgical Neurology International. 2025-01-01
Press Mentions
CASSINI Trial Assesses Rivaroxaban for Thromboprophylaxis in Cancer PatientsMarch 13th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
